XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholder Equity - USD ($)
$ in Millions
Total
Total stockholder equity
Common stock 
Capital surplus
(Accumulated deficit) Retained earnings
Treasury stock
Cumulative translation adjustment
Defined benefit postretirement plans
Cash flow hedging derivative
Non-controlling interest
Balance at beginning of period at Dec. 31, 2021 $ 3,745.3 $ 3,681.2 $ 0.0 $ 4,500.4 $ (761.8) $ (0.3) $ (52.6) $ (11.9) $ 7.4 $ 64.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (19.4) (25.1)     (25.1)         5.7
Equity-based compensation plans 38.7 38.7   38.7            
Dividends declared [1] (21.8) (21.8)   (21.8)            
Pension adjustments, net of tax benefit (0.2) (0.2)           (0.2)    
Change in cumulative translation adjustment, net of tax benefit (expense) (220.0) [2] (212.8)         (212.8)     (7.2)
Net investment hedge derivative, net of tax expense (benefit) 21.9 [3] 21.9         21.9      
Cash flow hedge derivative, net of tax expense 43.4 [4] 43.4             43.4  
Payment to non-controlling interest (0.3)                 (0.3)
Balance at end of period at Sep. 30, 2022 3,587.6 3,525.3 0.0 4,517.3 (786.9) (0.3) (243.5) (12.1) 50.8 62.3
Balance at beginning of period at Jun. 30, 2022 3,645.7 3,582.1 0.0 4,521.6 (794.9) (0.3) (170.5) (12.1) 38.3 63.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 10.4 8.0     8.0         2.4
Equity-based compensation plans 17.5 17.5   17.5            
Dividends declared [1] (21.8) (21.8)   (21.8)            
Change in cumulative translation adjustment, net of tax benefit (expense) (93.1) [2] (89.4)         (89.4)     (3.7)
Net investment hedge derivative, net of tax expense (benefit) 16.4 [3] 16.4         16.4      
Cash flow hedge derivative, net of tax expense 12.5 [4] 12.5             12.5  
Balance at end of period at Sep. 30, 2022 3,587.6 3,525.3 0.0 4,517.3 (786.9) (0.3) (243.5) (12.1) 50.8 62.3
Balance at beginning of period at Dec. 31, 2022 3,508.4 3,499.3 0.0 4,443.7 (764.1) (0.3) (170.3) (58.1) 48.4 9.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (46.3) (48.7)     (48.7)         2.4
Equity-based compensation plans 55.8 55.8   55.8            
Dividends declared [1] (65.6) (65.6)   (65.6)            
Pension adjustments, net of tax benefit (2.0) (2.0)           (2.0)    
Change in cumulative translation adjustment, net of tax benefit (expense) (33.7) [2] (33.6)         (33.6)     (0.1)
Net investment hedge derivative, net of tax expense (benefit) 3.1 [3] 3.1         3.1      
Cash flow hedge derivative, net of tax expense 4.0 [4] 4.0             4.0  
Balance at end of period at Sep. 30, 2023 3,423.7 3,412.3 0.0 4,433.9 (812.8) (0.3) (200.8) (60.1) 52.4 11.4
Balance at beginning of period at Jun. 30, 2023 3,449.6 3,438.9 0.0 4,438.6 (817.2) (0.3) (178.9) (59.4) 56.1 10.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 5.3 4.4     4.4         0.9
Equity-based compensation plans 17.2 17.2   17.2            
Dividends declared [1] (21.9) (21.9)   (21.9)            
Pension adjustments, net of tax benefit (0.7) (0.7)           (0.7)    
Change in cumulative translation adjustment, net of tax benefit (expense) (31.9) [2] (31.7)         (31.7)     (0.2)
Net investment hedge derivative, net of tax expense (benefit) 9.8 [3] 9.8         9.8      
Cash flow hedge derivative, net of tax expense (3.7) [4] (3.7)             (3.7)  
Balance at end of period at Sep. 30, 2023 $ 3,423.7 $ 3,412.3 $ 0.0 $ 4,433.9 $ (812.8) $ (0.3) $ (200.8) $ (60.1) $ 52.4 $ 11.4
[1] See Note 12 "Earnings (Loss) Per Share" for further discussion.
[2] Tax Expense (Benefit) of $(0.2) million and $(4.0) million for the three months ended September 30, 2023 and 2022, respectively. Tax Expense (Benefit) of $6.9 million and $(6.9) million for the nine months ended September 30, 2023 and 2022, respectively.
[3] Tax Expense (Benefit) of $0.1 million and $6.0 million for the three months ended September 30, 2023 and 2022, respectively. Tax Expense (Benefit) of $(2.3) million and $8.0 million for the nine months ended September 30, 2023 and 2022, respectively.
[4] Tax Expense (Benefit) of $(2.2) million and $4.5 million for the three months ended September 30, 2023 and 2022, respectively. Tax Expense (Benefit) of $0.5 million and $15.9 million for the nine months ended September 30, 2023 and 2022, respectively.